Daidzein-metabolizing phenotypes in relation to bone density and body composition among premenopausal women in the United States

Metabolism: Clinical and Experimental

Volumn 61, Issue 12, 2012, Pages 1678-1682

  Atkinson, Charlotte ^a   Newton, Katherine M ^b   Yong, Mellissa ^c   Stanczyk, Frank Z ^d   Westerlind, Kim C ^e   Li, Lin ^f   Lampe, Johanna W ^g,h  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c AMGEN INC   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f FLORIDA HOSPITAL   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Equol; Isoflavones; O desmethylangolensin; Soy challenge

Indexed keywords

DAIDZEIN; EQUOL;

ADULT; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE MINERAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PHYSICAL ACTIVITY; PREMENOPAUSE; PRIORITY JOURNAL; UNITED STATES;

ABSORPTIOMETRY, PHOTON; ADULT; BODY COMPOSITION; BONE DENSITY; CROSS-SECTIONAL STUDIES; EQUOL; FEMALE; FEMUR NECK; HUMANS; ILIUM; ISOFLAVONES; LUMBAR VERTEBRAE; MIDDLE AGED; PHENOTYPE; PHYTOESTROGENS; PREMENOPAUSE; SKULL; SOYBEANS; UNITED STATES;

EID: 84869488302     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.05.012     Document Type: Article

References (23)

1. C. Slemenda, C. Longcope, and M. Peacock Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women J Clin Invest 97 1996 14 21
2. D. Grenier, A.L. Cooke, and L. Lix Bone mineral density and risk of postmenopausal breast cancer Breast Cancer Res Treat 126 2011 679 686
3. D.S. Buist, A.Z. LaCroix, and W.E. Barlow Bone mineral density and breast cancer risk in postmenopausal women J Clin Epidemiol 54 2001 417 422 (Pubitemid 32303466)
4. C. Atkinson, C.L. Frankenfeld, and J.W. Lampe Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health Exp Biol Med (Maywood) 230 2005 155 170 (Pubitemid 40293689)
5. H. Adlercreutz, F. Martin, and M. Pulkkinen Intestinal metabolism of estrogens J Clin Endocrinol Metab 43 1976 497 505
6. C.L. Frankenfeld, A. McTiernan, and W.K. Thomas Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes Maturitas 53 2006 315 324 (Pubitemid 43163067)
7. H.S. Kwak, S.Y. Park, and M.G. Kim Marked individual variation in isoflavone metabolism after a soy challenge can modulate the skeletal effect of isoflavones in premenopausal women J Korean Med Sci 24 2009 867 873
8. K.D. Setchell, N.M. Brown, and E. Lydeking-Olsen The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones J Nutr 132 2002 3577 3584 (Pubitemid 35435031)
9. J. Wu, J. Oka, and J. Ezaki Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial Menopause 14 2007 866 874 (Pubitemid 47517585)
10. E. Brink, V. Coxam, and S. Robins Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study Am J Clin Nutr 87 2008 761 770 (Pubitemid 351364559)
11. S. Kreijkamp-Kaspers, L. Kok, and D.E. Grobbee Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial JAMA 292 2004 65 74 (Pubitemid 38923795)
12. A.M. Kenny, K.M. Mangano, and R.H. Abourizk Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trial Am J Clin Nutr 90 2009 234 242
13. J. Wu, J. Oka, and M. Higuchi Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial Metabolism 55 2006 423 433
14. C. Atkinson, K.M. Newton, and E.J. Bowles Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States Am J Clin Nutr 87 2008 679 687 (Pubitemid 351364550)
15. S.C. Karr, J.W. Lampe, and A.M. Hutchins Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption Am J Clin Nutr 66 1997 46 51 (Pubitemid 27278898)
16. C. Atkinson, K.M. Newton, and F.Z. Stanczyk Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States Cancer Causes Control 19 2008 1085 1093
17. D. Scholes, A.Z. Lacroix, and S.M. Ott Bone mineral density in women using depot medroxyprogesterone acetate for contraception Obstet Gynecol 93 1999 233 238 (Pubitemid 29068099)
18. T.V. Nguyen, J.R. Center, and J.A. Eisman Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study Maturitas 36 2000 27 34
19. W.E. Moore, and L.H. Moore Intestinal floras of populations that have a high risk of colon cancer Appl Environ Microbiol 61 1995 3202 3207
20. Y. Benno, K. Suzuki, and K. Suzuki Comparison of the fecal microflora in rural Japanese and urban Canadians Microbiol Immunol 30 1986 521 532 (Pubitemid 17182951)
21. A.S. Beard, and M.J. Blaser The ecology of height: the effect of microbial transmission on human height Perspect Biol Med 45 2002 475 498 (Pubitemid 35346229)
22. A.M. Duncan, B.E. Merz-Demlow, and X. Xu Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer Cancer Epidemiol Biomarkers Prev 9 2000 581 586 (Pubitemid 30396180)
23. K.D. Setchell, and S.J. Cole Method of defining equol-producer status and its frequency among vegetarians J Nutr 136 2006 2188 2193 (Pubitemid 44156823)